FUM vs. FARN, 4BB, SCLP, AVCT, POLB, REDX, ETX, HVO, TRX, and AREC
Should you be buying Futura Medical stock or one of its competitors? The main competitors of Futura Medical include Faron Pharmaceuticals Oy (FARN), 4basebio (4BB), Scancell (SCLP), Avacta Group (AVCT), Poolbeg Pharma (POLB), Redx Pharma (REDX), e-therapeutics (ETX), hVIVO (HVO), Tissue Regenix Group (TRX), and Arecor Therapeutics (AREC). These companies are all part of the "biotechnology" industry.
Futura Medical (LON:FUM) and Faron Pharmaceuticals Oy (LON:FARN) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, community ranking, media sentiment, institutional ownership and valuation.
Futura Medical has a beta of 1.28, meaning that its stock price is 28% more volatile than the S&P 500. Comparatively, Faron Pharmaceuticals Oy has a beta of -0.13, meaning that its stock price is 113% less volatile than the S&P 500.
37.1% of Futura Medical shares are owned by institutional investors. Comparatively, 12.7% of Faron Pharmaceuticals Oy shares are owned by institutional investors. 33.8% of Futura Medical shares are owned by company insiders. Comparatively, 39.3% of Faron Pharmaceuticals Oy shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
In the previous week, Futura Medical and Futura Medical both had 1 articles in the media. Futura Medical's average media sentiment score of 0.00 equaled Faron Pharmaceuticals Oy'saverage media sentiment score.
Faron Pharmaceuticals Oy received 131 more outperform votes than Futura Medical when rated by MarketBeat users. Likewise, 77.51% of users gave Faron Pharmaceuticals Oy an outperform vote while only 64.36% of users gave Futura Medical an outperform vote.
Faron Pharmaceuticals Oy has a net margin of 0.00% compared to Futura Medical's net margin of -210.03%. Faron Pharmaceuticals Oy's return on equity of 0.00% beat Futura Medical's return on equity.
Futura Medical has higher revenue and earnings than Faron Pharmaceuticals Oy. Futura Medical is trading at a lower price-to-earnings ratio than Faron Pharmaceuticals Oy, indicating that it is currently the more affordable of the two stocks.
Summary
Futura Medical beats Faron Pharmaceuticals Oy on 7 of the 13 factors compared between the two stocks.
Get Futura Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for FUM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding FUM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Futura Medical Competitors List
Related Companies and Tools
